Trial · NCT00763412
Results by group30
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 30
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| BMI | 1 Placebo | 19.63 | Full Range 15.56 to 22.64 | Kg/m^2 | |
| BMI | 2. Repaglinide | 21.19 | Full Range 20.78 to 21.8 | Kg/m^2 | |
| Body Composition | 1 Placebo | Fat | 19.82 | Full Range 12 to 37.8 | % body mass |
| Body Composition | 2. Repaglinide | Fat | 26.21 | Full Range 8.78 to 34.26 | % body mass |
| Body Composition | 1 Placebo | Lean | 77.15 | Full Range 59.54 to 87.84 | % body mass |
| Body Composition | 2. Repaglinide | Lean | 70.83 | Full Range 62.82 to 87.8 | % body mass |
| CRP | 1 Placebo | 9.6 | Full Range 0.7 to 27.5 | mg/L | |
| CRP | 2. Repaglinide | 2 | Full Range 0.6 to 3.7 | mg/L | |
| Glucose Tolerance | 1 Placebo | fasting glucose | 101.5 | Full Range 91 to 121 | mg/dl |
| Glucose Tolerance | 2. Repaglinide | fasting glucose | 94.5 | Full Range 85 to 108 | mg/dl |
| Glucose Tolerance | 1 Placebo | 2 hour glucose | 185.75 | Full Range 145 to 258 | mg/dl |
| Glucose Tolerance | 2. Repaglinide | 2 hour glucose | 184 | Full Range 123 to 266 | mg/dl |
| Inflammatory Markers | 1 Placebo | IL1 | 0.14 | Full Range 0.13 to 0.17 | pg/ml |
| Inflammatory Markers | 2. Repaglinide | IL1 | 0.34 | Full Range 0.13 to 1 | pg/ml |
| Inflammatory Markers | 1 Placebo | IL6 | 10.4 | Full Range 0.54 to 28.6 | pg/ml |
| Inflammatory Markers | 2. Repaglinide | IL6 | 6 | Full Range 2.2 to 11.9 | pg/ml |
| Inflammatory Markers | 1 Placebo | IL8 | 5.8 | Full Range 3.59 to 10.79 | pg/ml |
| Inflammatory Markers | 2. Repaglinide | IL8 | 5.2 | Full Range 3.1 to 8.33 | pg/ml |
| Inflammatory Markers | 1 Placebo | TNF alpha | 5.1 | Full Range 2.05 to 7.5 | pg/ml |
| Inflammatory Markers | 2. Repaglinide | TNF alpha | 3.6 | Full Range 1.99 to 5.3 | pg/ml |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00763412/results